Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alzamend Neuro, Aptatargets, Biogen, Canbridge, Icosavax, In8bio, Ionis, Morphic, Novavax, Pipeline, Prothena, Provention, Stalicla, Tiziana Life Sciences.